Transcript signatures that predict outcome and identify targetable pathways in MYCN‐amplified neuroblastoma
Robin Hallett(Hospital for Sick Children), Meredith S. Irwin(University of Toronto)
Cited by 17
Related Papers
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations
|Nature Cancer|2022|127
Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer
|PLoS ONE|2012|93